NPS Pharma Concludes Patient Randomisation In Gattex Phase 3 Registration Trial
NPS Pharma has randomised 86 patients in the Steps trial, evaluating the patients with parenteral nutrition (PN) dependent short bowel syndrome (SBS). NPS Pharma believes that the positive
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.